Role of homocysteine, cystathionine and methylmalonic acid measurement for diagnosis of vitamin deficiency in high‐aged subjects
Authors:
- 30 December 2000
- journal article
- research article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 30 (12) , 1083-1089
Abstract
Intracellular B‐vitamin and folate deficiency indicated by hyperhomocysteinemia is very frequent in the elderly population. Hyperhomocysteinemia increases the risk of atherothrombotic diseases and neuropsychiatric complications. Our aim was to evaluate the prevalence of increased serum metabolite concentrations in subjects of a higher age, and whether the measurement of metabolite concentrations is more effective in diagnosing B‐vitamin deficiency than mere homocysteine.Homocysteine (HCY), cystathionine (CYS) and methylmalonic acid (MMA) were investigated in serum together with vitamin B‐12, B‐6 and folate in 90 high‐aged subjects (85–102 years), 92 seniors (65–75 years), and in 50 younger subjects (19–50 years).Elderly subjects (high‐aged and senior) had elevated serum concentrations of metabolites. High‐aged subjects had a higher frequency of pathological increases than seniors: HCY 62% vs. 24%; MMA 62% vs. 23%; CYS 81% vs. 36%. Folate and vitamin B‐6 concentrations were significantly decreased in both elderly groups; vitamin B‐12 was only decreased in high‐aged subjects. Utilising vitamin B‐6, B‐12 and folate for diagnosis of intracellular vitamin deficiency, the rate was 30% in seniors and 55% in high aged subjects. However, utilising the metabolites (HCY, MMA and CYS) for the diagnosis of intracellular vitamin deficiency, there was a distinctly increased rate of 55% in seniors respective to 90% in high‐aged subjects. Backward multiple regression analysis revealed that only folate, MMA, creatinine and age were independent variables influencing the HCY concentration. Furthermore, the MMA concentration was significantly and independently influenced by folate, vitamin B‐12, HCY and creatinine, and the serum concentration of CYS by vitamin B‐12, creatinine and age.The metabolites HCY, MMA and CYS are sensitive indicators diagnosing impaired remethylation of homocysteine to methionine with parallel activation of catabolic pathway. Compared to mere HCY or B‐vitamins in serum, the efficiency of diagnosing a disturbed HCY metabolism increases very much in utilising the metabolites HCY, MMA and CYS. For differential diagnosis, parallel measurement of folate and creatinine is recommended. The early and correct diagnosis of B‐vitamin deficiency in elderly subjects is of high clinical relevance.Keywords
This publication has 38 references indexed in Scilit:
- Hyperhomocysteinemia in high-aged subjects: relation of B-vitamins, folic acid, renal function and the methylenetetrahydrofolate reductase mutationAtherosclerosis, 1999
- Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patientsKidney International, 1999
- The Role of Homocysteine in End‐Stage Renal DiseaseSeminars in Dialysis, 1998
- Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) excess in maintenance dialysis patients: a matched case-control studyAtherosclerosis, 1996
- The effect of a subnormal vitamin B-6 status on homocysteine metabolism.Journal of Clinical Investigation, 1996
- The effect of reduced glomerular filtration rate on plasma total homocysteine concentrationScandinavian Journal of Clinical and Laboratory Investigation, 1996
- Hyperhomocysteinaemia: a role in the accelerated atherogenesis of chronic renal failure?The Netherlands Journal of Medicine, 1995
- Hyperhomocyst(e)inemia as a Risk Factor for Occlusive Vascular DiseaseAnnual Review of Nutrition, 1992
- Age dependency of cystathionine beta-synthase activity in human fibroblasts in homocyst(e)inemia and atherosclerotic vascular diseaseAtherosclerosis, 1992
- Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke.Stroke, 1990